Rezultati

eNauka >  Rezultati >  Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
Naziv: Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
Autori De Backer, G.; Jankowski, P.; Dilić, M.; Lalić, N.; Lović, D.  ; Miličić, D.; Vulić, D.; Begić, A.; Durak Nalbantić, A.; Hadzibegić, N.;
Godina: 2019
Publikacija: Atherosclerosis
ISSN: 0021-9150 Atherosclerosis Pretraži identifikator
Izdavač: Elsevier Ireland Ltd
Tip rezultata: Naučni članak
Kolacija: vol. 285 str. 135-146
DOI: 10.1016/j.atherosclerosis.2019.03.014
WoS-ID: 000468732700018
Scopus-ID: 2-s2.0-85064931797
PMID: 31054483
URI: https://enauka.gov.rs/handle/123456789/572529
https://imagine.imgge.bg.ac.rs/handle/123456789/1231
Projekat: The EUROASPIRE V survey was carried out under the auspices of the ESC –EORP. Since the start of EORP, the following companies have supported the programme: Amgen, Eli Lilly, Pfizer, Sanofi, Ferrer and Novo Nordisk. The sponsors of the EUROASPIRE surveys had no role in the design, data collection, data analysis, data interpretation, decision to publish, or writing the manuscript. The EUROASPIRE Study Group is grateful to the administrative staff, physicians, nurses, and other personnel in the hospitals in which the survey was carried out and to all patients who participated in the surveys.
M-kategorija: 
21M21 - Rad u vrhunskom međ. časopisu

239
SCOPUSTM
89
PubMed CentralTM
141
OpenCitations
216
WEB OF SCIENCETM
Alt metrika
Dimensions

Pronađi DOI

Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.